Professor Christopher Hawkey
Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH
+44 115 823 1033 cj.hawkey@nottingham.ac.uk View full bio
Professor of Gastroenterology
Christopher Hawkey is Professor of Gastroenterology at the Nottingham Digestive Diseases Centre. His main interests are in the field of non-steroid anti-inflammatory drugs and inflammatory bowel disease. In both areas his approach is to try to identify targets in small exploratory studies and then evaluate them in large and/or outcomes studies.
Research Summary
Interests
- Non-steroidal anti-inflammatory drugs
- Inflammatory bowel disease
- Chemoprophylaxis of gastrointestinal cancers
Techniques
- Clinical trials including: Phase I assessments, particularly by endoscopy in volunteers Small proof of concept Phase II trials Clinical trial design, including Outcome studies
- Ex-vivo translational research
- Current research projects
- Target Outcomes Study of selective vs non-selective NSAIDs
Studies
| Title | Start Date | Status |
|---|---|---|
| A placebo-controlled, multiple dose, double-blind, randomized study to assess the efficacy and safet | 1st January 2012 | Ended |
Grants
| Title | Amount |
|---|---|
| Study to assess safety of GSK1605786A | £4,401 |
| ALL-HEART Allopurinol and cardiovascular outcome | £274,121 |
| FAST (PROBE) | £335,563 |
| Helicobacter Eradication vs Aspirin Toxicity | £1,819,174 |
| Subjects with moderately to severely active crohns | £3,126 |
| Standard Care Versus Celecoxib Outcome study | £285,599 |
Publications
